QGA
Q Global Advisors’s Ascendis Pharma ASND Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $44M | Buy |
255,000
+6,113
| +2% | +$1.06M | 37.03% | 1 |
|
|
2025
Q1 | $38.8M | Buy |
248,887
+29,428
| +13% | +$4.59M | 31.55% | 2 |
|
|
2024
Q4 | $30.2M | Hold |
219,459
| – | – | 31.14% | 1 |
|
|
2024
Q3 | $32.8M | Hold |
219,459
| – | – | 28.82% | 1 |
|
|
2024
Q2 | $29.9M | Sell |
219,459
-65,541
| -23% | -$8.94M | 21.23% | 1 |
|
|
2024
Q1 | $43.1M | Hold |
285,000
| – | – | 16.34% | 3 |
|
|
2023
Q4 | $35.9M | Hold |
285,000
| – | – | 27.2% | 1 |
|
|
2023
Q3 | $26.7M | Buy |
285,000
+90,000
| +46% | +$8.43M | 17.16% | 2 |
|
|
2023
Q2 | $17.4M | Buy |
195,000
+96,429
| +98% | +$8.61M | 12.55% | 4 |
|
|
2023
Q1 | $10.6M | Sell |
98,571
-52,838
| -35% | -$5.67M | 7.4% | 4 |
|
|
2022
Q4 | $18.5M | Buy |
151,409
+6,200
| +4% | +$757K | 8.95% | 5 |
|
|
2022
Q3 | $16.7M | Buy |
145,209
+25,209
| +21% | +$2.9M | 11.49% | 3 |
|
|
2022
Q2 | $11.2M | Sell |
120,000
-40,500
| -25% | -$3.76M | 8.65% | 4 |
|
|
2022
Q1 | $18.8M | Buy |
160,500
+44,615
| +38% | +$5.24M | 11.54% | 4 |
|
|
2021
Q4 | $15.6M | Buy |
115,885
+49,171
| +74% | +$6.61M | 3.58% | 6 |
|
|
2021
Q3 | $10.6M | Buy |
66,714
+16,993
| +34% | +$2.71M | 8.85% | 3 |
|
|
2021
Q2 | $6.54M | Buy |
49,721
+22,657
| +84% | +$2.98M | 4.57% | 4 |
|
|
2021
Q1 | $3.49M | Buy |
27,064
+3,881
| +17% | +$500K | 0.89% | 18 |
|
|
2020
Q4 | $3.87M | Buy |
+23,183
| New | +$3.87M | 2.72% | 7 |
|